The Substance Abuse and Mental Health Services Administration today issued new clinical guidance for treating pregnant and parenting women with opioid use disorder and their infants. The guidance consists of 16 factsheets containing clinical recommendations and resources to help health care professionals make evidence-informed decisions based on individual patient needs and local circumstances. “SAMHSA is filling an urgent need for reliable, useful and accurate information for health care professionals working to treat opioid-dependent mothers and their children,” said Elinore McCance-Katz, SAMHSA assistant secretary for mental health and substance use. “Ultimately, the steps explained in this guidance will help the mother and her infant safely receive treatment for opioid use disorder and neonatal abstinence syndrome.” In other news, the Senate Health, Education, Labor and Pensions Committee today held a hearing on the opioid crisis and its impact on children and families. Witnesses included Stephen Patrick, M.D., a pediatrician and neonatologist at Monroe Carell Jr. Children’s Hospital at Vanderbilt in Nashville and an assistant professor of pediatrics and health policy at Vanderbilt University School of Medicine.
 

Related News Articles

Headline
The Health Resources and Services Administration yesterday awarded 120 organizations, including hospitals, $200,000 each to develop community partnerships and…
Headline
Laws that allow pharmacists to dispense the opioid antidote naloxone without a physician’s prescription are associated with a sharp reduction in fatal opioid-…
Headline
The White House Office of National Drug Control Policy seeks by 2022 to reduce drug overdose deaths and youth illicit drug use by 15 percent and opioid…
Perspective
Investing in our country’s health infrastructure is the right move to make.
Headline
The AHA yesterday announced support for the Opioid Workforce Act of 2019, bipartisan legislation to reduce the nation’s shortage of opioid treatment providers…
Headline
The National Academy of Medicine Action Collaborative on Countering the U.S. Opioid Epidemic, of which the AHA is a sponsor, held a two-day meeting this week…